1. 164 AgenT-797, a novel allogenic and 'off-the shelf' iNKT cell therapy promotes effective tumor killing. (9th November 2020) Authors: Yigit, Burcu; Michelet, Xavier; Kharkwal, Shalu; Chantzoura, Eleni; Bergmann, Jan; Yague, Alvaro Sebastian; Yue, Simon; Moskowitz, Darrian; Wolf, Benjamin; Exley, Mark; Chand, Dhan; Dijk, Marc Van Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 164 AgenT-797, a novel allogenic and 'off-the shelf' iNKT cell therapy promotes effective tumor killing. (9th November 2020) Authors: Yigit, Burcu; Michelet, Xavier; Kharkwal, Shalu; Chantzoura, Eleni; Bergmann, Jan; Yague, Alvaro Sebastian; Yue, Simon; Moskowitz, Darrian; Wolf, Benjamin; Exley, Mark; Chand, Dhan; Dijk, Marc Van Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extracellular adenosine controls NKT‐cell‐dependent hepatitis induction. Issue 4 (19th February 2014) Authors: Subramanian, Meenakshi; Kini, Radhika; Madasu, Manasa; Ohta, Akiko; Nowak, Michael; Exley, Mark; Sitkovsky, Michail; Ohta, Akio Journal: European journal of immunology Issue: Volume 44:Issue 4(2014:Apr.) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗